KPIs & Operating Metrics(New)
Growth Metrics

Teva Pharmaceutical Industries (TEVA) Total Debt (2016 - 2025)

Historic Total Debt for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $16.8 billion.

  • Teva Pharmaceutical Industries' Total Debt fell 549.4% to $16.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $16.8 billion, marking a year-over-year decrease of 549.4%. This contributed to the annual value of $16.8 billion for FY2025, which is 549.4% down from last year.
  • Teva Pharmaceutical Industries' Total Debt amounted to $16.8 billion in Q4 2025, which was down 549.4% from $16.8 billion recorded in Q3 2025.
  • Teva Pharmaceutical Industries' 5-year Total Debt high stood at $25.1 billion for Q2 2021, and its period low was $16.7 billion during Q1 2025.
  • For the 5-year period, Teva Pharmaceutical Industries' Total Debt averaged around $20.4 billion, with its median value being $20.3 billion (2023).
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Total Debt crashed by 428.3% in 2021 and then crashed by 1523.62% in 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Total Debt (Quarter) stood at $23.0 billion in 2021, then decreased by 7.95% to $21.2 billion in 2022, then dropped by 6.5% to $19.8 billion in 2023, then dropped by 10.34% to $17.8 billion in 2024, then dropped by 5.49% to $16.8 billion in 2025.
  • Its Total Debt was $16.8 billion in Q4 2025, compared to $16.8 billion in Q3 2025 and $17.2 billion in Q2 2025.